Article
2q13 Distal Microdeletion: Considering Evidence for an Emerging Syndrome Versus Susceptibility Locus: Twenty-Five New Cases and Review of the Literature.
American journal of medical genetics. Part A - 1 Apr 2025
Elron Eyal, Shohat Mordechai, Basel-Salmon Lina, Kahana Sarit, Matar Reut, Klein Kochav, Agmon-Fishman Ifaat, Gurevitch Merav, Berger Rachel, Brabbing-Goldstein Dana, Levy Michal, Maya Idit
Abstract excerpt
This study investigates distal 2q13 microdeletion, presenting the largest cohort to date, including prenatal cases, alongside a comprehensive literature review. A retrospective analysis was conducted on distal 2q13 microdeletions from clinical charts and laboratory reports. The cohort was divided into "clinically indicated" and "not-clinically indicated" groups based on the reason for chromosomal microarray...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
